News
Memorial Hermann is laying off 83 employees due to the closure of the University Place senior living community and nursing ...
France 24 on MSN3h
The big business behind weight-loss drugs: Global market to hit $150 billion by 2035They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, ...
6h
MetDaan on MSNEnjoy these Easy and Yummy RecipesEnjoy these Easy and Yummy Recipes!! 'We will miss you so much': World mourns Portugal star Diogo Jota's tragic death Ford workers told their CEO ‘none of the young people want to work here.’ So Jim ...
LLY's non-obesity drugs like Verzenio and Taltz are fueling sales growth as investor focus stays on GLP-1 blockbusters.
DelveInsight's Sleep Apnea Market Insights report includes a comprehensive understanding of current treatment practices, sleep apnea emerging drugs, market share of individual therapies, and current ...
According to Regeneron, the drug is a bispecific antibody that binds to B-cell maturation antigen (BCMA) on cancerous plasma cells and CD3 on T cells, directing the immune system to attack and destroy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results